Trial NCT04315298
Publication Sivapalasingam S (2), 2021 ( double blinding)
Dates: 3/18/2020 to 7/2/2020
Funding: Private (Regeneron Pharmaceuticals, Inc. and Sanofi)
Conflict of interest: Yes